Back

Effect of beta-blockers on cardiovascular hospitalisation after myocardial infarction: A substudy of the BETAMI-DANBLOCK trial.

28 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Contemporary pharmacotherapy after acute coronary syndromes: beta-blockers, lipids, and platelet inhibition Beta-Blockers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Harun Caglar

Bispebjerg Hospital, Copenhagen (Denmark)

7 More presentations in this session

Presentation thumbnail
Troponin-stratified outcomes of extended clopidogrel monotherapy versus dual antiplatelet therapy in acute coronary syndrome: insights from the OPT-BIRISK randomized trial
Professor M. Qiu (Shenyang, CN)
Abstract Slides
Presentation thumbnail
Coordinated post-myocardial infarction care versus the PCSK9 modulator drug program: a comparative outcomes study
Professor M. Banach (Lodz, PL)
Abstract Slides
Presentation thumbnail
Long-term effect of beta-blockers after myocardial infarction with preserved left ventricular ejection fraction in a per protocol analysis of the REDUCE-AMI trial
Professor T. Jernberg (Stockholm, SE)
Abstract Slides
Presentation thumbnail
Long-term clinical outcomes of beta-blocker therapy in elderly patients with preserved left ventricular function after percutaneous coronary intervention for acute myocardial infarction
Assistant Professor J. Choe (Pusan, KR)
Abstract Slides
Presentation thumbnail
Impact of stepwise dual antiplatelet therapy de-escalation in patients with high bleeding risk undergoing drug-coated balloon angioplasty: Insights from the REC-CAGEFREE II trial
Associate Professor C. Gao (Hefei, CN)

Access the full session

Session thumbnail
Contemporary pharmacotherapy after acute coronary syndromes: beta-blockers, lipids, and platelet inhibition

The Event

Event poster

ESC Congress 2026

28 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Beta-blocker therapy and angina pectoris after myocardial infarction: a BETAMI-DANBLOCK substudy
23 April 2026
thumbnail
Congress Presentation
Discontinuation of guideline-recommended heart failure treatments after a first hospitalization for heart failure - An analysis from the SwedeHF registry
21 May 2022
thumbnail
Congress Presentation
Outcomes after first acute myocardial infarction in patients with and without adult congenital heart disease
30 August 2025
thumbnail
Congress Presentation
Beta-blocker interruption or continuation after myocardial infarction? a systematic review and meta-analysis
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources